Capital Research Global Investors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-557,461
| Closed | -$67.6M | – | 427 |
|
|
2023
Q3 | $67.6M | Buy |
557,461
+78
| +0% | +$9.46K | 0.02% | 304 |
|
|
2023
Q2 | $63.8M | Buy |
557,383
+291,442
| +110% | +$33.4M | 0.02% | 313 |
|
|
2023
Q1 | $36.7M | Buy |
+265,941
| New | +$36.7M | 0.01% | 343 |
|
|
2021
Q4 | – | Sell |
-2,542,191
| Closed | -$235M | – | 464 |
|
|
2021
Q3 | $235M | Sell |
2,542,191
-2,208,578
| -46% | -$204M | 0.05% | 234 |
|
|
2021
Q2 | $369M | Sell |
4,750,769
-3,276,134
| -41% | -$255M | 0.09% | 196 |
|
|
2021
Q1 | $598M | Buy |
8,026,903
+290,155
| +4% | +$21.6M | 0.15% | 139 |
|
|
2020
Q4 | $1.32B | Buy |
7,736,748
+1,025,424
| +15% | +$175M | 0.34% | 74 |
|
|
2020
Q3 | $942M | Buy |
6,711,324
+2,006,643
| +43% | +$282M | 0.28% | 83 |
|
|
2020
Q2 | $754M | Buy |
4,704,681
+829,723
| +21% | +$133M | 0.24% | 95 |
|
|
2020
Q1 | $379M | Buy |
3,874,958
+1,465,905
| +61% | +$143M | 0.15% | 128 |
|
|
2019
Q4 | $311M | Buy |
+2,409,053
| New | +$311M | 0.09% | 177 |
|